USP5 was reported to be a potential deubiquitinating enzyme for METTL3 in melanoma, and both USP5 knockout and the use of the USP5 inhibitor EOAI3402143 (EOAI) reduced METTL3 protein stability in A375 cells 25, 38. This evidence concerns the gene METTL3 and melanoma.